Boditech Med Inc. (KOSDAQ:206640)

Market Cap	347.77B
Revenue (ttm)	138.16B
Net Income (ttm)	27.26B
Shares Out	21.79M
EPS (ttm)	1,242.00
PE Ratio	12.85
Forward PE	9.89
Dividend	150.00 (0.94%)
Ex-Dividend Date	Mar 31, 2025

Volume	135,268
Average Volume	152,554
Open	16,010
Previous Close	16,000
Day's Range	15,850 - 16,250
52-Week Range	13,350 - 21,050
Beta	-0.61
RSI	58.62
Earnings Date	May 12, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 491
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.